Our community narratives are driven by numbers and valuation.
Value any stock for free in seconds
Get alerts and valuation updates
Participate in discussions
TO
Tokyo
Community Contributor
Investing in Stryker (SYK) should be an easy ride
Investing in Stryker (SYK) should be an easy ride Key “Take aways”: - Solid balance sheet - Earnings recovered, with positive outlook. - SYK is fair priced.
View narrativeUS$323.52
FV
16.3% overvalued intrinsic discount6.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
5 months ago author updated this narrative
WA
Consensus Narrative from 28 Analysts
New Products And Acquisitions Will Expand Offerings In Healthcare IT And Pain Management
Key Takeaways Strategic acquisitions and new product rollouts in healthcare IT and pain management are driving Stryker's revenue growth and market expansion. Increased operational efficiency and strategic pricing are boosting profitability, with significant margin expansion expected by 2025.
View narrativeUS$402.49
FV
6.5% undervalued intrinsic discount8.31%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Updated narrative